A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.

CONCLUSIONS: In this largest-to-date randomized controlled trial in uremic pruritus, NAL 120 durably and significantly reduced the itching intensity among hemodialysis patients.
PMID: 29253847 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - December 18, 2017 Category: Urology & Nephrology Authors: Mathur VS, Kumar J, Crawford PW, Hait H, Sciascia T, TR02 Study Investigators Tags: Am J Nephrol Source Type: research